We are live on ! Find out more
FLAM

First Light Asset Management Portfolio holdings

AUM $1.12B
1-Year Est. Return 114.45%
This Fund
S&P 500
This Quarter Est. Return
+13.71%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$1.67B
AUM Growth
+$159M
Cap. Flow
+$11.7M
Cap. Flow %
0.7%
Top 10 Hldgs %
44.6%
Holding
84
New
7
Increased
30
Reduced
18
Closed
5

Top Buys

Rank Stock Value
1
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
+$24.9M
2
ARNA
Arena Pharmaceuticals Inc
ARNA
+$17.7M
3
ATEC icon
Alphatec Holdings
ATEC
+$15.5M
4
INSM icon
Insmed
INSM
+$12.9M
5
RLAY icon
Relay Therapeutics
RLAY
+$12.9M

Top Sells

Rank Stock Value
1
PRTA icon
Prothena Corp
PRTA
+$31.4M
2
CDNA icon
CareDx
CDNA
+$25.2M
3
BTAI icon
BioXcel Therapeutics
BTAI
+$15.5M
4
MRVI icon
Maravai LifeSciences
MRVI
+$11.2M
5
HCAT icon
Health Catalyst
HCAT
+$11.1M

Sector Composition

Rank Sector Weight
1 Healthcare 83.7%
2 Communication Services 4.44%
3 Energy 0.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPNE
1
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
$123M 7.37%
5,988,509
+562,268
+10% +$11.6M
PRTA icon
2
Prothena Corp
PRTA
$425M
$99.1M 5.95%
1,927,829
-1,007,878
-34% -$31.4M
HALO icon
3
Halozyme
HALO
$9.79B
$93.1M 5.59%
2,050,273
+38,923
+2% +$1.72M
CDNA icon
4
CareDx
CDNA
$2.26B
$82M 4.92%
896,257
-316,420
-26% -$25.2M
MODN
5
DELISTED
MODEL N, INC.
MODN
$74.1M 4.44%
2,161,936
+212,174
+11% +$7.78M
ATRC icon
6
AtriCure
ATRC
$1.92B
$61.3M 3.68%
772,775
-55,227
-7% -$4.01M
OMCL icon
7
Omnicell
OMCL
$1.61B
$57.7M 3.46%
381,145
+2,070
+0.5% +$288K
NEO icon
8
NeoGenomics
NEO
$1.96B
$51.9M 3.11%
1,148,945
+145,729
+15% +$6.46M
TNDM icon
9
Tandem Diabetes Care
TNDM
$1.34B
$51.5M 3.09%
528,606
+3,477
+0.7% +$310K
CUTR
10
DELISTED
Cutera, Inc.
CUTR
$49.9M 2.99%
1,017,523
-226,594
-18% -$8.32M
AXGN icon
11
Axogen
AXGN
$2.27B
$48M 2.88%
2,221,673
-335,739
-13% -$6.79M
HCAT icon
12
Health Catalyst
HCAT
$154M
$43.8M 2.63%
789,393
-207,808
-21% -$11.1M
ARNA
13
DELISTED
Arena Pharmaceuticals Inc
ARNA
$42.1M 2.53%
617,124
+270,850
+78% +$17.7M
OPRX icon
14
OptimizeRx
OPRX
$114M
$41.2M 2.47%
664,842
+70,643
+12% +$3.59M
INSM icon
15
Insmed
INSM
$21.4B
$39.4M 2.37%
1,385,648
+434,695
+46% +$12.9M
ALDX icon
16
Aldeyra Therapeutics
ALDX
$92.9M
$39.3M 2.36%
3,471,459
+847,458
+32% +$10.2M
ARWR icon
17
Arrowhead Research
ARWR
$11.9B
$38.6M 2.31%
465,572
-71,264
-13% -$5.31M
STRO icon
18
Sutro Biopharma
STRO
$401M
$38.5M 2.31%
207,288
+1,443
+0.7% +$282K
XENT
19
DELISTED
Intersect ENT, Inc
XENT
$37.8M 2.27%
2,210,970
+174,325
+9% +$3.26M
KRYS icon
20
Krystal Biotech
KRYS
$10.1B
$35.8M 2.15%
526,650
+35,139
+7% +$2.45M
GKOS icon
21
Glaukos
GKOS
$9.83B
$34.7M 2.08%
409,144
-123,513
-23% -$10.1M
YMAB
22
DELISTED
Y-mAbs Therapeutics
YMAB
$32.1M 1.93%
950,192
+5,939
+0.6% +$191K
KRTX
23
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$31.3M 1.88%
274,780
+16,280
+6% +$1.9M
TPTX
24
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$30.9M 1.85%
395,825
+336,946
+572% +$24.9M
TEVA icon
25
Teva Pharmaceuticals
TEVA
$40.8B
$29.4M 1.77%
2,973,092
-701,012
-19% -$7.42M
1
2 3 4

Similar funds

AIM
Advyzon Investment Management Lisle, Illinois $1.12B AUM 22.08% 1-Year Est. Return
MTCM
Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return
CNC
Canandaigua National Corp Canandaigua, New York $1.12B AUM
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
RIM
Rockbridge Investment Management Syracuse, New York $1.11B AUM 13.62% 1-Year Est. Return
CT
Caldwell Trust Venice, Florida $1.12B AUM 21.31% 1-Year Est. Return
SL
Salomon & Ludwin Richmond, Virginia $1.12B AUM 14.38% 1-Year Est. Return
HH
Hilltop Holdings Dallas, Texas $1.11B AUM 24.7% 1-Year Est. Return

First Light Asset Management's Q2 2021 Portfolio in Review

As of Q2 2021, First Light Asset Management held 84 positions worth $1.67B, up 11% from $1.51B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

First Light Asset Management's Q2 2021 filing shows 7 new, 30 increased, 18 reduced and 5 closed positions. Its largest new stake was Relay Therapeutics: 390,555 shares worth $14.3M. The largest sale was Prothena Corp, an estimated $31.4M.

By sector, the portfolio is most concentrated in Healthcare at 84% of assets, down from 84% a quarter earlier, followed by Communication Services and Energy.

  • First Light Asset Management's largest Q2 2021 buy was Relay Therapeutics: 390,555 shares worth $14.3M.
  • First Light Asset Management added most to Turning Point Therapeutics, Inc. Common Stock in Q2 2021, an estimated $24.9M increase.
  • First Light Asset Management's biggest Q2 2021 reduction was Prothena Corp, cutting an estimated $31.4M.
  • First Light Asset Management fully exited BioXcel Therapeutics in Q2 2021, selling an estimated $15.5M.
  • First Light Asset Management's ten largest holdings make up 45% of its $1.67B portfolio in Q2 2021.
  • First Light Asset Management opened 7 new positions and closed 5 in Q2 2021.
  • First Light Asset Management's portfolio value rose 11% quarter-over-quarter to $1.67B.

Based on First Light Asset Management's 13F filing for Q2 2021, filed 13 Aug 2021.